30 related articles for article (PubMed ID: 694476)
1. Increased plasma DR-70 (fibrinogen-fibrin degradation products) concentrations as a diagnostic biomarker in dogs with neoplasms.
Ke CH; Sio KM; Wu CH; Xia YY; Lee JJ; Hu CH; Liu CC; Lu CL; Cheng CL; Lin KH; Tomiyasu H; Wang YS; Lin CS
J Vet Intern Med; 2023; 37(6):2391-2401. PubMed ID: 37837297
[TBL] [Abstract][Full Text] [Related]
2. Enhanced fibrinolysis detection in a natural occurring canine model with intracavitary effusions: Comparison and degree of agreement between thromboelastometry and FDPs, D-dimer and fibrinogen concentrations.
Zoia A; Drigo M; Piek CJ; Calcini H; Caldin M; Simioni P
PLoS One; 2019; 14(11):e0225089. PubMed ID: 31725761
[TBL] [Abstract][Full Text] [Related]
3. Hemostatic findings of pleural fluid in dogs and the association between pleural effusions and primary hyperfibrino(geno)lysis: A cohort study of 99 dogs.
Zoia A; Drigo M; Piek CJ; Simioni P; Caldin M
PLoS One; 2018; 13(2):e0192371. PubMed ID: 29462172
[TBL] [Abstract][Full Text] [Related]
4. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
Mombelli G; Monotti R; Haeberli A; Straub PW
Thromb Haemost; 1987 Aug; 58(2):758-63. PubMed ID: 3672428
[TBL] [Abstract][Full Text] [Related]
5. Fibrinogen catabolism within the procoagulant VX-2 tumor of rabbit lung in vivo: Effluxing fibrin(ogen) fragments contain antiangiogenic activity.
Hatton MW; Southward SM; Legault KJ; Ross BL; Clarke BJ; Bajzar L; Blajchman MA; Singh G; Richardson M
J Lab Clin Med; 2004 Apr; 143(4):241-54. PubMed ID: 15085083
[TBL] [Abstract][Full Text] [Related]
6. Relationships among tumor burden, tumor size, and the changing concentrations of fibrin degradation products and fibrinolytic factors in the pleural effusions of rabbits with VX2 lung tumors.
Hatton MW; Southward SM; Ross BL; Clarke BJ; Singh G; Richardson M
J Lab Clin Med; 2006 Jan; 147(1):27-35. PubMed ID: 16443002
[TBL] [Abstract][Full Text] [Related]
7. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.
Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T
Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021
[TBL] [Abstract][Full Text] [Related]
8. [Biological significance of fibrinopeptide A elevation in the blood].
Mombelli G; Hofmann V; Straub PW
Schweiz Med Wochenschr; 1977 Dec; 107(48):1779-81. PubMed ID: 579262
[TBL] [Abstract][Full Text] [Related]
9. Fibrinogen, fibrin(ogen) degradation products and fibrinopeptide A in pleural effusions. High turnover of fibrinogen in pleurisy.
Widström O; Kockum C; Nilsson BS
Scand J Respir Dis; 1978 Aug; 59(4):210-5. PubMed ID: 694476
[TBL] [Abstract][Full Text] [Related]
10. [Role of proteases, plasminogen activators, fibrin fibrinogen degradation products and fibrinopeptides in the growth and development of neoplasms and neoplasm metastases].
Farbiszewski R
Postepy Hig Med Dosw; 1984; 38(2):133-55. PubMed ID: 6393101
[No Abstract] [Full Text] [Related]
11. Novel aspects of fibrin(ogen) fragments during inflammation.
Jennewein C; Tran N; Paulus P; Ellinghaus P; Eble JA; Zacharowski K
Mol Med; 2011; 17(5-6):568-73. PubMed ID: 21210072
[TBL] [Abstract][Full Text] [Related]
12. Fibrinogen, fibrin and the arterial wall.
Smith EB
Eur Heart J; 1995 Mar; 16 Suppl A():11-4; discussion 14-5. PubMed ID: 7796823
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
